vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Noble Corp plc (NE). Click either name above to swap in a different company.
Noble Corp plc is the larger business by last-quarter revenue ($764.4M vs $493.8M, roughly 1.5× Pediatrix Medical Group, Inc.). Noble Corp plc runs the higher net margin — 11.3% vs 6.8%, a 4.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -17.6%). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
MD vs NE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $764.4M |
| Net Profit | $33.7M | $86.6M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 5.6% |
| Net Margin | 6.8% | 11.3% |
| Revenue YoY | -1.7% | -17.6% |
| Net Profit YoY | 10.5% | -10.4% |
| EPS (diluted) | $0.40 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $764.4M | ||
| Q3 25 | $492.9M | $798.0M | ||
| Q2 25 | $468.8M | $848.7M | ||
| Q1 25 | $458.4M | $874.5M | ||
| Q4 24 | $502.4M | $927.3M | ||
| Q3 24 | $511.2M | $800.5M | ||
| Q2 24 | $504.3M | $692.8M | ||
| Q1 24 | $495.1M | $637.1M |
| Q4 25 | $33.7M | $86.6M | ||
| Q3 25 | $71.7M | $-21.1M | ||
| Q2 25 | $39.3M | $42.9M | ||
| Q1 25 | $20.7M | $108.3M | ||
| Q4 24 | $30.5M | $96.6M | ||
| Q3 24 | $19.4M | $61.2M | ||
| Q2 24 | $-153.0M | $195.0M | ||
| Q1 24 | $4.0M | $95.5M |
| Q4 25 | 9.9% | 5.6% | ||
| Q3 25 | 13.8% | 6.3% | ||
| Q2 25 | 12.8% | 15.9% | ||
| Q1 25 | 7.0% | 21.4% | ||
| Q4 24 | 7.8% | 18.4% | ||
| Q3 24 | 6.6% | 14.4% | ||
| Q2 24 | -31.3% | 30.3% | ||
| Q1 24 | 3.2% | 16.9% |
| Q4 25 | 6.8% | 11.3% | ||
| Q3 25 | 14.5% | -2.6% | ||
| Q2 25 | 8.4% | 5.1% | ||
| Q1 25 | 4.5% | 12.4% | ||
| Q4 24 | 6.1% | 10.4% | ||
| Q3 24 | 3.8% | 7.6% | ||
| Q2 24 | -30.3% | 28.1% | ||
| Q1 24 | 0.8% | 15.0% |
| Q4 25 | $0.40 | $0.54 | ||
| Q3 25 | $0.84 | $-0.13 | ||
| Q2 25 | $0.46 | $0.27 | ||
| Q1 25 | $0.24 | $0.67 | ||
| Q4 24 | $0.37 | $0.56 | ||
| Q3 24 | $0.23 | $0.40 | ||
| Q2 24 | $-1.84 | $1.34 | ||
| Q1 24 | $0.05 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $471.4M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $4.5B |
| Total Assets | $2.2B | $7.5B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $471.4M | ||
| Q3 25 | $340.1M | $477.9M | ||
| Q2 25 | $224.7M | $338.2M | ||
| Q1 25 | $99.0M | $303.8M | ||
| Q4 24 | $229.9M | $247.3M | ||
| Q3 24 | $103.8M | $391.9M | ||
| Q2 24 | $19.4M | $162.9M | ||
| Q1 24 | $8.0M | $212.5M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $4.5B | ||
| Q3 25 | $890.7M | $4.5B | ||
| Q2 25 | $833.8M | $4.6B | ||
| Q1 25 | $789.2M | $4.7B | ||
| Q4 24 | $764.9M | $4.7B | ||
| Q3 24 | $732.5M | $4.7B | ||
| Q2 24 | $706.5M | $4.0B | ||
| Q1 24 | $856.2M | $3.9B |
| Q4 25 | $2.2B | $7.5B | ||
| Q3 25 | $2.2B | $7.6B | ||
| Q2 25 | $2.1B | $7.7B | ||
| Q1 25 | $2.0B | $7.9B | ||
| Q4 24 | $2.2B | $8.0B | ||
| Q3 24 | $2.1B | $8.0B | ||
| Q2 24 | $2.0B | $5.6B | ||
| Q1 24 | $2.2B | $5.4B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $187.1M |
| Free Cash FlowOCF − Capex | — | $35.4M |
| FCF MarginFCF / Revenue | — | 4.6% |
| Capex IntensityCapex / Revenue | — | 19.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | $432.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $187.1M | ||
| Q3 25 | $137.3M | $277.1M | ||
| Q2 25 | $137.2M | $216.4M | ||
| Q1 25 | $-117.5M | $271.1M | ||
| Q4 24 | $133.0M | $136.2M | ||
| Q3 24 | $91.8M | $283.8M | ||
| Q2 24 | $107.0M | $106.8M | ||
| Q1 24 | $-125.2M | $128.7M |
| Q4 25 | — | $35.4M | ||
| Q3 25 | — | $139.5M | ||
| Q2 25 | — | $99.8M | ||
| Q1 25 | — | $157.5M | ||
| Q4 24 | — | $-4.4M | ||
| Q3 24 | — | $156.8M | ||
| Q2 24 | — | $-34.3M | ||
| Q1 24 | — | $-37.9M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 17.5% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 18.0% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | — | -4.9% | ||
| Q1 24 | — | -6.0% |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 17.3% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 20.4% | ||
| Q1 24 | — | 26.2% |
| Q4 25 | 3.39× | 2.16× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 5.05× | ||
| Q1 25 | -5.66× | 2.50× | ||
| Q4 24 | 4.36× | 1.41× | ||
| Q3 24 | 4.72× | 4.64× | ||
| Q2 24 | — | 0.55× | ||
| Q1 24 | -31.03× | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
